 Halozyme Therapeutics, Inc. NASDAQ:HALO Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Tram Bui - Vice President, Investor Relations Corporate Communication Helen Torley - President Chief Executive Officer Nicole LaBrosse - Chief Financial Officer Conference Call Participants Mike DiFiore - Evercore Corinne Jenkins - Goldman Sachs David Risinger - SVB Securities Jessica Fye - JPM Chase Operator Good afternoon. My name is Rex, and I will be your conference operator today. 